Assessing the product pipeline is very useful for various prospects like approval of the product, competition in the market, value of the product for out-licensing, in-licensing or for joint development, evaluation of milestone payments and royalty etc. Further, assessing the pipeline is often the most important part of valuing a pharmaceutical company, and the most difficult. The value of a pipeline is the sum of the values of each drug in the pipeline. To assess the value of a drug in the pipeline one needs to consider various factors like- the size of potential market for the drug, how much market share the drug will be able to gain (depend on its cost and effectiveness compared to competitors), and the risk that it will not be approved.
Insight Pharma Innova is the service by IBRSoluTions for pharmaceutical innovator companies and investors want to invest on new chemical entity. It tracks and evaluates drugs worldwide through the entire development process, from discovery, through pre-clinical and clinical studies to launch. It is common for companies to buy and sell drugs that are in various stages of development, or to enter into agreements to jointly develop or market drugs. In these circumstances one company may receive milestone payments from another for completing particular stages of development, trials and approval, as well as royalties on the drug once it is marketed.
IBRSoluTions provides insights of new innovative pharmaceutical products helping our clients in various aspects like
Monitor the progress of competitor’s R&D programs
Evaluate the strengths and weaknesses of compounds
Assess the commercial potential of upcoming products
Access key scientific data to support licensing opportunities
Review success/failure rates of companies or technologies